| ID: | 113 | |
|---|---|---|
| Name: | Compound 113 | |
| Description: | Original numeration in publication: D-1 | |
| Labels: | Test_set, Nicotinamide-pyridine | |
| CAS: | ||
| InChi Code: | InChI=1S/C20H18N4O/c1-15(23-24-19-7-3-2-4-8-19)16-9-11-18(12-10-16)22-20(25)17-6-5-13-21-14-17/h2-14,24H,1H3,(H,22,25)/b23-15+ |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 7.64 |
Yousef, R. G.; Ibrahim, A.; Khalifa, M. M. a. E., W. M.; Gobaara, I. M. M.; Mehany, A. B. M. a. E., E. B.; Alsfouk, A. A.; Metwaly, A. M. a. E., I. H. Discovery of new nicotinamides as apoptotic VEGFR-2 inhibitors: virtual screening, synthesis, anti-proliferative, immunomodulatory, ADMET, toxicity, and molecular dynamic simulation studies. J. Enzyme Inhib. Med. Chem. 2022, 37, 1389–1403. https://doi.org/10.1080/14756366.2022.2070744 |
| 7.25205 |
Eq1: VEGFR-2 inhibition (Data used to validate model) |